Utility of glypican-3, alpha-fetoprotein, and HepPar-1 as a panel for detecting hepatocellular carcinoma in fine needle aspiration biopsies

被引：0
|
作者：
LaCaria, T. M. [1 ]
Teot, L. A. [1 ]
Cai, G. [1 ]
机构：
[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
来源：
LABORATORY INVESTIGATION | 2008年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
349
引用
收藏
页码：78A / 78A
页数：1
相关论文
共 46 条
  • [31] Discriminating Hepatocellular Carcinoma From Metastatic Carcinoma on Fine-Needle Aspiration Biopsy of the Liver: The Utility of Immunocytochemical Panel
    Saleh, Husain A.
    Aulicino, Michael
    Zaidi, Sayed Y.
    Khan, Aurang Zeb
    Masood, Shahla
    DIAGNOSTIC CYTOPATHOLOGY, 2009, 37 (03) : 184 - 190
  • [32] HCRP1, ID4 and Glypican-3: an optimal panel of biomarkers for diagnosis of hepatocellular carcinoma
    Ge, Shujian
    Wang, Dan
    Lv, Beibei
    Yang, Shuping
    Liu, Chunmei
    Xu, Bin
    Zhao, Chunming
    Qin, Yejun
    Xu, Jiawen
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (12): : 5774 - 5782
  • [33] A prospective study of the utility of lectin-reactive alpha-fetoprotein (AFP-L3%) in developing hepatocellular carcinoma (HCC)
    Sterling, Richard
    Stravitz, Richard
    Luketic, Velimir
    Fuchs, Michael
    Sanyal, Arun
    Shiffman, Mitchell
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S118 - S118
  • [34] Diagnostic value of Hepatocyte Paraffin 1 antibody to discriminate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsies of the liver
    Zimmerman, RL
    Burke, MA
    Young, NA
    Solomides, CC
    Bibbo, M
    CANCER CYTOPATHOLOGY, 2001, 93 (04): : 288 - 291
  • [35] Diagnostic Utility of SALL4 in Extragonadal Yolk Sac Tumors An Immunohistochemical Study of 59 Cases With Comparison to Placental-like Alkaline Phosphatase, Alpha-fetoprotein, and Glypican-3
    Wang, Fenghua
    Liu, Aijun
    Peng, Yan
    Rakheja, Dinesh
    Wei, Lixin
    Xue, Debing
    Allan, Robert W.
    Molberg, Kyle H.
    Li, Jianping
    Cao, Dengfeng
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2009, 33 (10) : 1529 - 1539
  • [36] Utility of an Immunohistochemical Panel Consisting of Glypican-3, Heat-shock Protein-70, and Glutamine Synthetase in the Distinction of Low-grade Hepatocellular Carcinoma From Hepatocellular Adenoma
    Lagana, Stephen M.
    Salomao, Marcela
    Bao, Fei
    Moreira, Roger K.
    Lefkowitch, Jay H.
    Remotti, Helen E.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2013, 21 (02) : 170 - 176
  • [37] Diagnostic value of HepPar1 pCEA, CD10, and CD34 expression in separating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration cytology
    Saad, RS
    Luckasevic, TM
    Noga, CM
    Johnson, DR
    Silverman, JF
    Liu, YLL
    DIAGNOSTIC CYTOPATHOLOGY, 2004, 30 (01) : 1 - 6
  • [38] Risk of developing hepatocellular carcinoma (HCC) in patients with cirrhosis of viral etiology evaluated by the association of alpha-fetoprotein (AFP), protein induced by vitamin K absence or antagonist-II (PIVKA-II) and glypican-3 (GPC-3)
    Caviglia, G. P.
    Abate, M. L.
    Ciruolo, M.
    Carucci, P.
    Olivero, A.
    Rolle, E.
    Rosso, C.
    Younes, R.
    Ciancio, A.
    Smedile, A.
    Saracco, G. M.
    Bugianesi, E.
    Gaia, S.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : E54 - E54
  • [39] The diagnostic utility of the Hep Par 1 antibody to differentiate hepatocellular carcinoma (HCC) from metastatic carcinoma (MC) in fine needle aspiration (FNA) samples.
    Siddiqui, MT
    Saboorian, MH
    Ashfaq, R
    MODERN PATHOLOGY, 2001, 14 (01) : 62A - 62A
  • [40] The diagnostic utility of the Hep Par 1 antibody to differentiate hepatocellular carcinoma (HCC) from metastatic carcinoma (MC) in fine needle aspiration (FNA) samples.
    Siddiqui, MT
    Saboorian, MH
    Ashfaq, R
    LABORATORY INVESTIGATION, 2001, 81 (01) : 62A - 62A
12345